Ganga Pharmaceuticals Fair Value

Fair Value Analysis Export

P/E Based Valuation

Current EPS ₹0.1
Sector Avg P/E 22.49
Historical Avg P/E N/A
Average Fair Value
₹1.92

P/B Based Valuation

Book Value/Share ₹13.33
Sector Avg P/B 6.25
Historical Avg P/B N/A
Average Fair Value
₹51.66

Asset-Based Valuation

Book Value/Share ₹13.33
Liquidation Value/Share ₹11.67
Fair Value
₹13.33

Benjamin Graham Number

Current EPS ₹0.1
Book Value/Share ₹13.33
Graham Multiplier 22.5
Current P/E 488.2
Graham Criteria 1/3
Graham Number
₹5.48
Criteria Met: P/B ≤ 1.5

GANGAPHARM Fair Value Analysis — Data Sources & Coverage

Ganga Pharmaceuticals financial data sources, valuation methods applied and sector benchmarks used. Check Ganga Pharmaceuticals networth to track the company's total market size over time.

Methods Used
4
Sector
Healthcare

Available Data Sources: Financial statements, balance sheet data , sector comparisons.

GANGAPHARM vs Healthcare Sector Peers — P/E, P/B & Market Cap

Ganga Pharmaceuticals P/E ratio, P/B ratio and market capitalisation vs Healthcare sector peers — relative valuation comparison.

Company Symbol P/E Ratio P/B Ratio Market Cap (₹ Cr)
Kerala Ayurveda KERALAYUR -7.9 18.27 ₹225
Jeena Sikho Lifecare JSLL 28.36 14.35 ₹6,506
Sat Kartar Life SATKARTAR 11.08 2.77 ₹191
Sun Pharmaceutical SUNPHARMA 38.12 5.53 ₹463,072
Auro Laboratories AUROLAB 80.95 3.46 ₹148

Important Disclaimer

This fair value analysis is for informational and educational purposes only. The calculations are based on publicly available financial data and various valuation methodologies.

This analysis does not constitute investment advice, recommendations, or suggestions to buy, sell, or hold any securities. Past performance and financial data do not guarantee future results.

Please conduct your own research and consult with qualified financial advisors before making any investment decisions. Market conditions, company fundamentals, and other factors can significantly impact actual stock performance.